Anti-myelin associated glycoprotein (MAG) antibodies

Details for Australian Patent Application No. 2003255390 (hide)

Owner Glaxo Group Limited

Inventors Germaschewski, Volker; Ellis, Jonathan Henry

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003255390

PCT Number PCT/EP03/08749

PCT Pub. Number WO2004/014953

Priority 0218232.7 06.08.02 GB; 0218230.1 06.08.02 GB; 0218229.3 06.08.02 GB; 0218234.3 06.08.02 GB

Filing date 5 August 2003

Wipo publication date 25 February 2004

Acceptance publication date 3 February 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

6 November 2003 Complete Application Filed

  Priority application(s): 0218232.7 06.08.02 GB; 0218230.1 06.08.02 GB; 0218229.3 06.08.02 GB; 0218234.3 06.08.02 GB

8 April 2004 Application Open to Public Inspection

  Published as AU-B-2003255390

3 February 2011 Application Accepted

  Published as AU-B-2003255390

2 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003255391-MECHANICAL DEPOSITION PROCESS

2003255389-PYRIMIDO COMPOUNDS HAVING ANTIPROLIFERATIVE ACTIVITY